Skip to content

EBIT at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
ALN
Alnylam PharmaceuticalsALNY
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
Royalty Pharma logo
Royalty PharmaRPRX
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$73.7M-86.4%
Operating income-$141.3M-137%
Net income-$132.7M-136%
EPS (diluted)-$0.93-134%

Balance sheet

See full
Cash & equivalents$188.5M+1.5%
Total debt$107.9M-5.6%
Total equity$614.0M-10.1%
Total assets$2.3B+44.2%

Cash flow

See full
Operating cash flow$84.4M-81.6%
CapEx$2.6M-51.6%
Free cash flow$81.9M-82.0%

Valuation

See full
Market cap$11.52B+402%
Enterprise value$11.44B+418%
P/S18.5×+14.3×

Profitability

See full
Operating margin-35.7%+63.6pp
Net margin-48.4%+240pp
FCF margin1.8%+0.9pp

Returns & leverage

See full
Return on equity-46.4%+341pp
Debt / equity0.2×0.0×
Current ratio6.2×+1.1×

Where this comes from

Calculated from Arrowhead Research’s reported figures.

The official record: Arrowhead Research’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arrowhead Research's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arrowhead Research's EBIT?
Arrowhead Research (ARWR) reported EBIT of -$141.26M in Q1 2026.
How has Arrowhead Research's EBIT changed year-over-year?
Arrowhead Research's EBIT decreased by 137.1% year-over-year, from $381.2M to -$141.26M.
What is the long-term trend for Arrowhead Research's EBIT?
Over 4 years (2021 to 2025), Arrowhead Research's EBIT has grown at a -9.9% compound annual growth rate (CAGR), from -$149.04M to $98.35M.
What does EBIT mean?
Profit before interest and taxes — the business's core earning power.
How do you interpret EBIT?
Higher is better. Because it adds back interest, EBIT compares earning power across firms with very different debt loads — the base for interest coverage and the EV/EBIT multiple. For filers reporting operating income it equals that line, excluding non-operating swings.
How does EBIT compare across companies?
Comparable across companies regardless of leverage or tax domicile; the standard 'earning power' line for cross-company analysis. Least meaningful for banks and insurers.